Key Metrics of Addex Therapeutics Ltd
Market cap$5.0MADXN · $2.93
Competitors10identified
About Addex Therapeutics Ltd
Sectors
Company details
- Website
- addexpharma.com
- Listed
- Nasdaq: ADXN
Operational Areas of Addex Therapeutics Ltd
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameAddex Therapeutics Ltd
TickerADXN
ExchangeNasdaq
CountrySwitzerland
SEC CIK0001574232
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttp://www.addexpharma.com
US market & SEC filings
ADXN · Nasdaq · SEC CIK 0001574232
Last price · 31 Oct 2026
$2.93
−1.01%
Market cap$5.0M
P/E—
Volume2,366
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOSwitzerland
ADXN share price
Annual results (SEC EDGAR)
No annual results in SEC XBRL data for this company yet.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officePlan-les-Ouates
GSTIN—
Email—
Websitehttp://www.addexpharma.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Addex Therapeutics Ltd
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | twistbioscience.com | 2018 | United States |
Similar companies
E
Elanco Animal Health IncorporatedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
M
Medtronic plc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
S
Summit Therapeutics Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
ICON plc (ICLR)Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
Charles River Laboratories International Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
Ascendis Pharma A/S Ordinary SharePharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
M
Medpace Holdings Inc.Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
Insmed IncorporatedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.